Agios Pharmaceuticals reported $28.26M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Amgen AMGN:US $ 1.33B 99M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Astellas Pharma 4503:JP 153.4B 10.98B
AstraZeneca AZN:LN 3.27B 209M
Bayer BAYN:GR 4.47B 527M
Biogen BIIB:US $ 572.6M 62.3M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Bristol Myers Squibb BMY:US $ 1.78B 46M
Cerulean Pharma CERU:US $ 2.59M 168.34K
Daiichi Sankyo 4568:JP 96.37B 8.36B
Eli Lilly And LLY:US $ 1.63B 67.2M
Epizyme EPZM:US $ 24.11M 3.09M
Exelixis EXEL:US $ 122.76M 19.9M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Immunogen IMGN:US $ 23.79M 7.14M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
JAZZ PHA JAZZ:US 325.67M 16.86M
Merk MRK:US $ 2.42B 118M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Moderna Inc MRNA:US 211M 57M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Novartis NVS:US 3.59B 91M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Puma Biotechnology PBYI:US $ 20.58M 174K
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Seattle Genetics SGEN:US $ 220.26M 46.03M
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
YTE INCY:US $ 253.28M 43.69M